off-label use of glp-1 agonists for obesity in 2016 GLP1 Receptor Agonists—Effects beyond and Diabetes Use of diabetes and anti-obesity

It mimics not just one but two hormones: GLP-1 and GIP

JAMA - J Am Med Assoc 315(1):3646

[DOI] [PMC free article] [PubMed] [Google Scholar] 84

Microbiol 80 , 29912997 (2014)

Lotte Bjerre Knudsen giving a keynote talk at the 12th ARDD This historic pivot signals that the longevity field has arrived in the mainstream

Economic And Other Project Specific Considerations 4 Executive Summary 5 Introduction 6 Market Landscape: GLP-1 Drugs 7 GLP-1 Drugs: Detailed Company Profiles 8 GLP-1 Drugs: Brief Company Profiles 9 Partnerships And Collaborations 10 Market Impact Analysis: Drivers, Restraints, Opportunities And Challenges 11 Global GLP-1 Market 12 GLP-1 Market, By Type Of Molecule 13 GLP-1 Market, By Active Compound Used 14 GLP-1 Market, By Type Of GLP-1 Agonist Drugs 15 GLP-1 Market, By GLP-1 Agonist 16 GLP-1 Market, By Route Of Administration 17 GLP-1 Market, By Target Indication 18 GLP-1 Market, By Geography 19 GLP-1 Market, Sales Forecast Of GLP-1 Drugs 20 GLP-1 Market, By Leading Drug Developers 21 Appendix 1: Tabulated Data 22 Appendix 2: List Of Companies And Organizations Additional Benefits Complimentary PPT Insights Packs Complimentary Excel Data Packs for all Analytical Modules in the Report 10% Free Content Customization Detailed Report Walkthrough Session with Research Team Free Updated report if the report is 6-12 months old or older For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data